Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone

OBJECTIVE: The objective of this study was to assess the efficacy and safety of nabilone, a synthetic tetrahydrocannabinol analogue, as a treatment for non‐motor symptoms (NMS) in Parkinson's disease (PD). METHODS: This was a phase II placebo‐controlled, double‐blind, parallel‐group, enriched e...

Descripción completa

Detalles Bibliográficos
Autores principales: Peball, Marina, Krismer, Florian, Knaus, Hans‐Günther, Djamshidian, Atbin, Werkmann, Mario, Carbone, Federico, Ellmerer, Philipp, Heim, Beatrice, Marini, Kathrin, Valent, Dora, Goebel, Georg, Ulmer, Hanno, Stockner, Heike, Wenning, Gregor K., Stolz, Raphaela, Krejcy, Kurt, Poewe, Werner, Seppi, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540547/
https://www.ncbi.nlm.nih.gov/pubmed/32757413
http://dx.doi.org/10.1002/ana.25864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540547/
https://www.ncbi.nlm.nih.gov/pubmed/32757413
http://dx.doi.org/10.1002/ana.25864

Ejemplares similares